MAKING SCIENCE GROUP SA (ALMKS.PA) Fundamental Analysis & Valuation

EPA:ALMKS • ES0105463006

8.35 EUR
0 (0%)
Last: Mar 3, 2026, 07:00 PM

This ALMKS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALMKS. ALMKS was compared to 65 industry peers in the Media industry. ALMKS has a bad profitability rating. Also its financial health evaluation is rather negative. ALMKS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. ALMKS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALMKS has reported negative net income.
  • ALMKS had a positive operating cash flow in the past year.
  • In the past 5 years ALMKS reported 4 times negative net income.
  • ALMKS had a positive operating cash flow in 4 of the past 5 years.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

  • The Return On Assets of ALMKS (-0.99%) is worse than 67.69% of its industry peers.
  • With a Return On Equity value of -6.62%, ALMKS is not doing good in the industry: 67.69% of the companies in the same industry are doing better.
  • With a decent Return On Invested Capital value of 7.51%, ALMKS is doing good in the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
ROA -0.99%
ROE -6.62%
ROIC 7.51%
ROA(3y)-2.49%
ROA(5y)-1.44%
ROE(3y)-23.01%
ROE(5y)-9.95%
ROIC(3y)N/A
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

  • ALMKS has a Operating Margin of 1.86%. This is in the lower half of the industry: ALMKS underperforms 60.00% of its industry peers.
  • ALMKS's Operating Margin has declined in the last couple of years.
  • ALMKS's Gross Margin of 20.80% is on the low side compared to the rest of the industry. ALMKS is outperformed by 80.00% of its industry peers.
  • ALMKS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.86%
PM (TTM) N/A
GM 20.8%
OM growth 3YN/A
OM growth 5Y-6.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.93%
GM growth 5Y-5%
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

2

2. ALMKS.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALMKS is creating some value.
  • ALMKS has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALMKS has more shares outstanding
  • Compared to 1 year ago, ALMKS has an improved debt to assets ratio.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 1.73, we must say that ALMKS is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.73, ALMKS is in line with its industry, outperforming 60.00% of the companies in the same industry.
  • ALMKS has a debt to FCF ratio of 1140.00. This is a negative value and a sign of low solvency as ALMKS would need 1140.00 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 1140.00, ALMKS is not doing good in the industry: 66.15% of the companies in the same industry are doing better.
  • ALMKS has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ALMKS (0.46) is better than 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1140
Altman-Z 1.73
ROIC/WACC1.1
WACC6.85%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • ALMKS has a Current Ratio of 0.76. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.76, ALMKS is doing worse than 70.77% of the companies in the same industry.
  • A Quick Ratio of 0.73 indicates that ALMKS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.73, ALMKS is doing worse than 64.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.73
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

6

3. ALMKS.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 61.58% over the past year.
  • The Revenue has grown by 16.22% in the past year. This is quite good.
  • Measured over the past years, ALMKS shows a very strong growth in Revenue. The Revenue has been growing by 51.26% on average per year.
EPS 1Y (TTM)61.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-323.33%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y35.39%
Revenue growth 5Y51.26%
Sales Q2Q%21.45%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.62% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 21.95% on average over the next years. This is a very strong growth
EPS Next Y-27.27%
EPS Next 2Y11.46%
EPS Next 3Y15.62%
EPS Next 5YN/A
Revenue Next Year33.94%
Revenue Next 2Y25.99%
Revenue Next 3Y21.95%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

0

4. ALMKS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALMKS. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 34.11, the valuation of ALMKS can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALMKS indicates a slightly more expensive valuation: ALMKS is more expensive than 60.00% of the companies listed in the same industry.
  • ALMKS is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 34.11
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 80

4.2 Price Multiples

  • 61.54% of the companies in the same industry are cheaper than ALMKS, based on the Enterprise Value to EBITDA ratio.
  • 66.15% of the companies in the same industry are cheaper than ALMKS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1518.03
EV/EBITDA 9.24
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALMKS's earnings are expected to grow with 15.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.46%
EPS Next 3Y15.62%

0

5. ALMKS.PA Dividend Analysis

5.1 Amount

  • ALMKS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALMKS.PA Fundamentals: All Metrics, Ratios and Statistics

MAKING SCIENCE GROUP SA

EPA:ALMKS (3/3/2026, 7:00:00 PM)

8.35

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-31
Earnings (Next)N/A
Inst Owners3.56%
Inst Owner ChangeN/A
Ins Owners61.03%
Ins Owner ChangeN/A
Market Cap75.90M
Revenue(TTM)274.00M
Net Income(TTM)-1.72M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.11
P/S 0.28
P/FCF 1518.03
P/OCF 230
P/B 2.92
P/tB N/A
EV/EBITDA 9.24
EPS(TTM)-0.2
EYN/A
EPS(NY)0.24
Fwd EY2.93%
FCF(TTM)0.01
FCFY0.07%
OCF(TTM)0.04
OCFY0.43%
SpS30.14
BVpS2.86
TBVpS-4.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.99%
ROE -6.62%
ROCE 10.22%
ROIC 7.51%
ROICexc 13.46%
ROICexgc N/A
OM 1.86%
PM (TTM) N/A
GM 20.8%
FCFM 0.02%
ROA(3y)-2.49%
ROA(5y)-1.44%
ROE(3y)-23.01%
ROE(5y)-9.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-6.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.93%
GM growth 5Y-5%
F-Score6
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1140
Debt/EBITDA 1.03
Cap/Depr 4.29%
Cap/Sales 0.1%
Interest Coverage 1.14
Cash Conversion 2.84%
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.73
Altman-Z 1.73
F-Score6
WACC6.85%
ROIC/WACC1.1
Cap/Depr(3y)13.72%
Cap/Depr(5y)311.76%
Cap/Sales(3y)0.4%
Cap/Sales(5y)7.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-323.33%
EPS Next Y-27.27%
EPS Next 2Y11.46%
EPS Next 3Y15.62%
EPS Next 5YN/A
Revenue 1Y (TTM)16.22%
Revenue growth 3Y35.39%
Revenue growth 5Y51.26%
Sales Q2Q%21.45%
Revenue Next Year33.94%
Revenue Next 2Y25.99%
Revenue Next 3Y21.95%
Revenue Next 5YN/A
EBIT growth 1Y278.77%
EBIT growth 3YN/A
EBIT growth 5Y41.58%
EBIT Next Year145.61%
EBIT Next 3Y41.06%
EBIT Next 5YN/A
FCF growth 1Y103.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y178.57%
OCF growth 3Y-64.23%
OCF growth 5YN/A

MAKING SCIENCE GROUP SA / ALMKS.PA FAQ

What is the fundamental rating for ALMKS stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMKS.PA.


Can you provide the valuation status for MAKING SCIENCE GROUP SA?

ChartMill assigns a valuation rating of 0 / 10 to MAKING SCIENCE GROUP SA (ALMKS.PA). This can be considered as Overvalued.


What is the profitability of ALMKS stock?

MAKING SCIENCE GROUP SA (ALMKS.PA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for MAKING SCIENCE GROUP SA?

The Earnings per Share (EPS) of MAKING SCIENCE GROUP SA (ALMKS.PA) is expected to decline by -27.27% in the next year.